Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
2.920
+0.090 (3.18%)
At close: Aug 29, 2025, 4:00 PM
2.959
+0.039 (1.33%)
After-hours: Aug 29, 2025, 6:41 PM EDT

Taysha Gene Therapies Stock Forecast

Stock Price Forecast

The 7 analysts that cover Taysha Gene Therapies stock have a consensus rating of "Strong Buy" and an average price target of $8.71, which forecasts a 198.29% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $14.

Price Target: $8.71 (+198.29%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$6.00$8.71$8.00$14
Change+105.48%+198.29%+173.97%+379.45%

Analyst Ratings

The average analyst rating for Taysha Gene Therapies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy443344
Buy444423
Hold000000
Sell000000
Strong Sell000000
Total887767

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wells Fargo
Wells Fargo
Buy
Maintains
$7.5$8
BuyMaintains$7.5$8+173.97%Aug 13, 2025
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$11$14
Strong BuyMaintains$11$14+379.45%Aug 13, 2025
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$9$10
Strong BuyMaintains$9$10+242.47%Aug 12, 2025
B of A Securities
B of A Securities
Strong Buy
Initiates
$8
Strong BuyInitiates$8+173.97%Jul 11, 2025
Needham
Needham
Strong Buy
Reiterates
$8
Strong BuyReiterates$8+173.97%Jul 1, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
7.55M
from 8.33M
Decreased by -9.43%
Revenue Next Year
4.17M
from 7.55M
Decreased by -44.79%
EPS This Year
-0.36
from -0.36
EPS Next Year
-0.43
from -0.36
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
--2.50M15.45M8.33M7.55M4.17M
Revenue Growth
---517.55%-46.07%-9.43%-44.79%
EPS
-3.40-4.64-3.78-0.96-0.36-0.36-0.43
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1514
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High15.8M15.8M
Avg7.5M4.2M
Low2.3Mn/a

Revenue Growth

Revenue Growth20252026202720282029
High
89.0%
108.7%
Avg
-9.4%
-44.8%
Low
-73.0%
-

EPS Forecast

EPS20252026202720282029
High-0.34-0.37
Avg-0.36-0.43
Low-0.38-0.54

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.